Caracterización de la población de pacientes diabéticos tipo 2 en el Hospital Militar Central

dc.contributoroswaldo, rincon
dc.creatoralvarez vargas, duvan alfonso
dc.creatorrodriguez salas, gustavo jose
dc.creatoruscategui ruiz, adriana catalina
dc.creatoroswaldo, rincon
dc.date.accessioned2022-02-09T17:34:01Z
dc.date.accessioned2022-09-28T21:31:51Z
dc.date.available2022-02-09T17:34:01Z
dc.date.available2022-09-28T21:31:51Z
dc.date.created2022-02-09T17:34:01Z
dc.date.issued2022-01-31
dc.identifierhttp://hdl.handle.net/10654/40001
dc.identifierinstname:Universidad Militar Nueva Granada
dc.identifierreponame:Repositorio Institucional Universidad Militar Nueva Granada
dc.identifierrepourl:https://repository.unimilitar.edu.co
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3746578
dc.description.abstractIntroducción: La diabetes mellitus (DM) describe un trastorno que implica metabolismo anormal de carbohidratos, lípidos y proteínas caracterizado por hiperglicemia. La prevalencia es alta a nivel mundial, con tasa importante de morbimortalidad, siendo una de las condiciones que más aporta desenlaces adversos en cuanto a riesgo cardiovascular. El objetivo de este estudio fue caracterizar la población de pacientes con diagnóstico de diabetes mellitus tipo 2 (T2DM) en el Hospital Militar Central (HMC). Métodos: Se realizó un estudio descriptivo de corte transversal. Se recolectaron datos de identificación de los pacientes a través del registro de atención del programa de clínica de diabetes en los años 2018 y 2019. Para el análisis final, las variables cualitativas se resumieron en frecuencias y porcentajes y las variables cuantitativas, de acuerdo con distribución en promedio o mediana con su respectiva medida de dispersión. Resultados: 635 pacientes analizados, mediana de edad 70 (59-79), hombres 56,7% (360/635), diabetes tipo 2 87,1% (552), uso de metformina 54,9 % (348 /635), uso de insulina glargina 53,1% (337/635), pacientes con complicaciones 48,2% (306/365) Conclusiones: Los pacientes de este estudio reflejan las dificultades de países de medianos y bajos ingresos en la atención de los pacientes diabéticos, especialmente por la presencia de complicaciones y comorbilidades asociadas a esta patología.
dc.languagespa
dc.publisherMedicina Interna
dc.publisherFacultad de Medicina
dc.publisherUniversidad Militar Nueva Granada
dc.relationPower D. Standards of medical care in diabetes: Response to position statement of the American Diabetes Association [20]. Diabetes Care. 2006;29(2):476.
dc.relationOf D, Mellitus D. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(SUPPL.1):81–90.
dc.relationPaneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part i. Eur Heart J. 2013;34(31):2436–46.
dc.relationPeter V. Chin-Hong M. Infections in Patients With Diabetes Mellitus : and Prevention. Infect Dis. 2006;6(2):71–81.
dc.relationKramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo study. Diabetes Care. 2010;33(1):101–3.
dc.relationYang W, Dall TM, Beronjia K, Lin J, Semilla AP, Chakrabarti R, et al. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917–28.
dc.relationIDF Diabetes Atlas. International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium. International Diabetes Federation. 2015. 144 p. Available from: http://www.diabetesatlas.org
dc.relationHerrera Lopez A. Análisis de Situación de Salud ( ASIS ) Dirección de Epidemiología y Demografía. Bogotá; 2018.
dc.relationEmerging T, Factors R. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. 2011;
dc.relationCare D, Suppl SS. 2 . Classification and Diagnosis of Diabetes : Standards of Medical Care in Diabetes d 2019. 2019;42(January):13–28.
dc.relationMoreno Segura C. Analisis de situación de salud (ASIS) Colombia. Bogotá; 2018.
dc.relationXu G, Liu B, Sun Y, Du Y, Snetselaar LG, Hu FB, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: Population based study. BMJ. 2018;362.
dc.relationPrevention C for DC and. National Diabetes Statistics Report. Atlanta, Georgia; 2017.
dc.relationWang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA - J Am Med Assoc. 2017;317(24):2515–23.
dc.relationVargas-Uricoechea H, Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Ann Glob Heal [Internet]. 2015;81(6):742–53.
dc.relationScott RA, Langenberg C, Sharp SJ, Franks PW, Rolandsson O, Drogan D, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: The EPIC-InterAct study. Diabetologia. 2013;56(1):60–9.
dc.relationMeigs JB, Cupples LA, Wilson PWF. The Framingham Offspring Study. (23):2201–7.
dc.relationShai I, Jiang R, Manson JAE, Stampfer MJ, Willett WC, Colditz GA, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: A 20-year follow-up study. Diabetes Care. 2006;29(7):1585–90.
dc.relationMokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc. 2003;289(1):76–9.
dc.relationGroup DR, Young. The New England Journal of Medicine Downloaded from nejm.org on March 29, 2011. For personal use only. No other uses without permission. N Engl J Med. 1993;329(14):977–86.
dc.relationColditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–6.
dc.relationAndy Menke, Keith F Rust, Judith Fradkin, Yiling J Cheng, Catherine C Cowie. (2014 sep ). Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med, 2, 161.
dc.relationRury R Holman 1, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. (2008 Oct 9). 10-year follow-up of intensive glucose control in type 2 diabetes. new england journal of medicine , 359, 15.
dc.relationJinan B Saaddine 1, Anne Fagot-Campagna, Deborah Rolka, K M Venkat Narayan, Linda Geiss, Mark Eberhardt, Katherine M Flegal. (2002 aug). Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. diabetes care, 1326, 30.
dc.relationACCORD Study Group; ACCORD Eye Study Group; Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue, David C Goff Jr, William C Cushman, Henry N Ginsberg, Marshall B Elam, Saul Genuth, Hertzel C Gerstein, Ulrich Schubart, Lawrence J Fine. (2010 Jul 15). Effects of medical therapies on retinopathy progression in type 2 diabetes. new england journal of medicine , 363, 233.
dc.relationFaramarz Ismail-Beigi 1, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm Jr, Bruce P Hamilton, Byron Hoogwerf, Diane Karl, Lois Katz, Armand Krikorian, Patrick O'Connor, Rodica Pop-Busui, Ulrich Schubart, Debra Simmons, Harris Taylor, Abraham Thomas, Daniel Weiss, Irene Hramiak, ACCORD trial group. (2010 Aug 7 ). Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. lancet , 376, 419.
dc.relationADVANCE Collaborative Group; Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee, Pavel Hamet, Stephen Harrap, Simon Heller, Lisheng Liu, Giuseppe Mancia, Carl Erik Mogensen, Changyu Pan, Neil Poulter, Anthony Rodgers, Bryan Williams, Severine Bompoint, Bastiaan E de Galan, Rohina Joshi, Florence Travert. (2008 Jun 12). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal Of Medicine, 358, 72.
dc.relationSophia Zoungas 1, John Chalmers, Bruce Neal, Laurent Billot, Qiang Li, Yoichiro Hirakawa, Hisatomi Arima, Helen Monaghan, Rohina Joshi, Stephen Colagiuri, Mark E Cooper, Paul Glasziou, Diederick Grobbee, Pavel Hamet, Stephen Harrap, Simon Heller, Liu Lisheng, Giuseppe Mancia, Michel Marre, David R Matthews, Carl E Mogensen, Vlado Perkovic, Neil Poulter, Anthony Rodgers, Bryan Williams, Stephen MacMahon, Anushka Patel, Mark Woodward, ADVANCE-ON Collaborative Group. (2014 Oct 9). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal Of Medicine, 371, 406.
dc.relationIDF, Diabetes Atlas. In. Edited by Federation ID, 9th edn, 2019
dc.relationSaeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843.
dc.relationVargas-Uricoechea H, Casas-Figueroa LÁ. An Epidemiologic Analysis of Diabetes in Colombia. Ann Glob Health. 2015 Nov-Dec;81(6):742-53.
dc.relationEinarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018 Jun 8;17(1):83.
dc.relationKwon Y, Kim HJ, Park S, Park YG, Cho KH. Body Mass Index-Related Mortality in Patients with Type 2 Diabetes and Heterogeneity in Obesity Paradox Studies: A Dose-Response Meta-Analysis. PLoS One. 2017 Jan 3;12(1):e0168247.
dc.relationKoye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis. 2018 Mar;25(2):121-132.
dc.relationMiranda-Machado P, Salcedo-Mejía F, Wilches JP, Fernandez-Mercado J, De la Hoz-Restrepo F, Alvis-Guzmán N. First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study. BMC Cardiovasc Disord. 2019 Jan 8;19(1):8.
dc.relationSelvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010 Mar 4;362(9):800-11.
dc.relationMontvida O, Shaw J, Atherton JJ, Stringer F, Paul SK. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes. Diabetes Care. 2018 Jan;41(1):69-78.
dc.relationSarkar S, Heyward J, Alexander GC, Kalyani RR. Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020. JAMA Netw Open. 2021 Oct 1;4(10):e2128782.
dc.relationZelada H, Bernabe-Ortiz A, Manrique H. Inhospital Mortality in Patients with Type 2 Diabetes Mellitus: A Prospective Cohort Study in Lima, Peru. J Diabetes Res. 2016;2016:7287215.
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAcceso abierto
dc.titleCaracterización de la población de pacientes diabéticos tipo 2 en el Hospital Militar Central


Este ítem pertenece a la siguiente institución